Test filters

News

In the media

Press releases

Publications

Scientific articles

Statements

Stories

Videos

Viewpoints

In the media

27 May 2026

The Long, Strange Journey of Mycetoma Research

Global Health Now

Scientific articles

14 May 2026

In vitro profiling of Trypanosoma cruzi inhibitors identified from high throughput screening and application to parasite painting

International Journal for Parasitology: Drugs and Drug Resistance

Statements

19 May 2026

DNDi interventions at the 79^th World Health Assembly

Statements

15 May 2026

DNDi statement on hantavirus outbreak: ‘Investment in pandemic preparedness efforts remains insufficient.’

Scientific articles

13 May 2026

Chemical genetics reveals Leishmania KKT2 and CRK9 kinase activity is required for cell cycle progression

PLOS Pathogens

Statements

13 May 2026

DNDi’s briefing note for 79^th World Health Assembly

Press releases

12 May 2026

DNDi welcomes GHIT support for global evaluation and registration of fosravuconazole for eumycetoma, in collaboration with Eisai

In the media

29 Apr 2026

Thailand approves ravidasvir, a new drug for hepatitis C, increasing chances of complete cure

Thai Rath

Scientific articles

14 May 2026

Mycetoma as a major cause of limb amputation in Northeastern Ethiopia: A facility-based retrospective study

PLOS Neglected Tropical Diseases

In the media

6 May 2026

Fourteen days to recovery from kala-azar

Nature Africa

Scientific articles

30 Apr 2026

Overcoming Trypanosoma cruzi persistence with a mechanistically distinct drug combination

npj Antimicrobials and Resistance

In the media

29 Apr 2026

ไทยรับรอง “ราวิดาสเวียร์” ยาใหม่รักษาไวรัสตับอักเสบซี เพิ่มโอกาสรักษาหายขาด

Thai Rath

Press releases

27 Apr 2026

Thailand registers ravidasvir, a simple-to-use and effective antiviral for hepatitis C, expanding treatment options for Thai patients

In the media

25 Apr 2026

‘Estamos na fase de eliminação’: RD Congo avança no combate à doença que matou milhões na África

Alma Preta

In the media

24 Apr 2026

Dengue treatments in 2-3 years, but cases set to rise with climate change

Times of India

In the media

23 Apr 2026

India eyes dengue treatment rollout within five years as vaccine pipeline advances

The New Indian Express

International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

The Long, Strange Journey of Mycetoma Research

In vitro profiling of Trypanosoma cruzi inhibitors identified from high throughput screening and application to parasite painting

DNDi interventions at the 79^th World Health Assembly

DNDi statement on hantavirus outbreak: ‘Investment in pandemic preparedness efforts remains insufficient.’

Chemical genetics reveals Leishmania KKT2 and CRK9 kinase activity is required for cell cycle progression

DNDi’s briefing note for 79^th World Health Assembly

DNDi welcomes GHIT support for global evaluation and registration of fosravuconazole for eumycetoma, in collaboration with Eisai

Thailand approves ravidasvir, a new drug for hepatitis C, increasing chances of complete cure

Mycetoma as a major cause of limb amputation in Northeastern Ethiopia: A facility-based retrospective study

Fourteen days to recovery from kala-azar

Overcoming Trypanosoma cruzi persistence with a mechanistically distinct drug combination

ไทยรับรอง “ราวิดาสเวียร์” ยาใหม่รักษาไวรัสตับอักเสบซี เพิ่มโอกาสรักษาหายขาด

Thailand registers ravidasvir, a simple-to-use and effective antiviral for hepatitis C, expanding treatment options for Thai patients

‘Estamos na fase de eliminação’: RD Congo avança no combate à doença que matou milhões na África

Dengue treatments in 2-3 years, but cases set to rise with climate change

India eyes dengue treatment rollout within five years as vaccine pipeline advances

Learn more

Get in touch

Support us

Work with us